Where does Dyax Corp. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Dyax Corp. ranks #6,135 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Dyax Corp. hold?

Dyax Corp. holds 55 US utility patents granted between 2015 and 2021, spanning 12 technology areas.

What is Dyax Corp.'s Innovation Score?

Dyax Corp. has an Innovation Score of 36.1 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Dyax Corp. focus on?

Dyax Corp.'s top technology area is C07K (Peptides) with 36 patents, ranking #266 of 3,615 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Dyax Corp.'s patent grant rate increasing or decreasing?

Dyax Corp.'s recent grant velocity is -72% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Dyax Corp.'s patents?

Dyax Corp.'s patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Dyax Corp. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Dyax Corp.

USPTO PatentsView assignee record - 55 granted patents across 12 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dyax ranks #6,135 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 12 technology areas.

#6,135
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.1/100): 16.6
avg claims per patent: -72%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6135 · US Corporation #6,135 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 55 grants
UPPER-Q #6,135/49,997
PHOTO-FINISH CureVac SE
CPC-FOCUS C07K · 12 areas
INNOV-THIN 36.1/100
CLAIMS-RICH 16.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -72% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: CureVac SE (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dyax’s 36.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.9 pts (39%) Velocity 0.0 pts (0%) Breadth 12.2 pts (34%) Claim depth 9.9 pts (28%)

Qualcomm Incorporated · highest

85
Aerin Medical · near

36
Dyax · this assignee

36
Magnolia White · near

36
Mako Rentals · near

36
WaveLight · near

36
3D Lighting… · lowest

7

What this shows Dyax's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Dyax?

Each dot is one of Dyax’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dyax’s own 16.6 claims/patent is at or below the 17.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Dyax vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dyax's grants concentrate

Dyax Corp. is a focused PatentsView assignee: 12 CPC subclasses with 65.5% of grants classified under C07K (Peptides). Peak complete grant year is 2017 (13 grants) versus a trough of 3 in 2021. By volume, Dyax sits between CureVac SE and East Carolina University.

Curevac SE

55
Custom Molded Pro…

55
Dental Imaging

55
DT Swiss

55
Elkay Manufacturi…

55
Enzo Life Sciences

55
Eugene Technology

55
East Carolina Uni…

55
Dyax ◀

55

What this shows Dyax holds 55 patents at rank #6,135, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dyax

By rank, the assignees closest to #6,135 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Dyax's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Dyax, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Dyax ranks #266 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Aerin Medical Inc. 36 WaveLight GmbH 36 Magnolia White Corporation 36 Mako Rentals, Inc. 36

Similar claim depth

Nearest assignees by average claims per patent (16.6 here).

Ultrahaptics IP Ltd 16.6 avg Mastercard ASIA/PACIFIC PTE. Ltd. 16.6 avg THE University OF Ottawa 16.6 avg Arbor Networks, Inc. 16.6 avg

Dyax's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Dyax Corp. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	12	21.8%
2016	8	14.5%
2017	13	23.6%
2018	4	7.3%
2019	6	10.9%
2020	9	16.4%
2021	3	5.5%

Which technologies does Dyax Corp. patent most?

C07K - Peptides 36

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 25

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 25

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 24

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 23

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 20

Y02A - Technologies FOR Adaptation TO Climate Change 3

B03C - Magnetic OR Electrostatic Separation OF Solid Materials From Solid Materials OR FLUIDS; Separation BY High-voltage Electric Fields 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

A61B - DIAGNOSIS; SURGERY; Identification 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Dyax Corp.'s patent record in context - here's where to go next.

Dyax Corp.'s lead technology class is C07K (Peptides), 65.5% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #6,135 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Dyax Corp. against CureVac SE, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.